BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 2298269)

  • 1. In vitro purging of clonogenic leukaemic cells from human bone marrow by interferon-gamma-activated monocytes.
    van de Loosdrecht AA; Ossenkoppele GJ; Beelen RH; Broekhoven MG; Schweitzer KM; Langenhuijsen MM
    Cancer Immunol Immunother; 1994 May; 38(5):346-52. PubMed ID: 8162617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgM monoclonal antibody JD118 recognizes an inducible antigen target for human-complement-mediated cytotoxicity against neoplastic B cells.
    Czuczman MS; Garin-Chesa P; Lemoli RM; Scheinberg DA
    Cancer Immunol Immunother; 1993 Jun; 36(6):387-96. PubMed ID: 8500111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of monoclonal antibodies against individually immunophenotyped human leukemic cells.
    Beksac M; Porwit-Ksiazek A; Hast R; Biberfeld P; Reizenstein P
    Cancer Immunol Immunother; 1985; 19(3):231-6. PubMed ID: 3859364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular Complement (Complosome) is Expressed in Several Types of Human Adult Bone Marrow-Derived Stem Cells.
    Bujko K; Brzenziakiewicz-Janus K; Kucia M; Ratajczak MZ
    Stem Cell Rev Rep; 2024 Jan; 20(1):437-439. PubMed ID: 37917411
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficient B cell depletion via diphtheria toxin in CD19-Cre/iDTR mice.
    Demircik F; Buch T; Waisman A
    PLoS One; 2013; 8(3):e60643. PubMed ID: 23544158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial experience with treatment of human B cell lymphoma with anti-CD19 monoclonal antibody.
    Hekman A; Honselaar A; Vuist WM; Sein JJ; Rodenhuis S; ten Bokkel Huinink WW; Somers R; Rümke P; Melief CJ
    Cancer Immunol Immunother; 1991; 32(6):364-72. PubMed ID: 1706642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Removal of neoplastic cells from autologous bone marrow grafts with monoclonal antibodies.
    Jansen J; Falkenburg JH; Stepan DE; LeBien TW
    Semin Hematol; 1984 Jul; 21(3):164-81. PubMed ID: 6379879
    [No Abstract]   [Full Text] [Related]  

  • 8. Autologous bone marrow transplantation in acute leukemia and lymphoma following ex vivo treatment with monoclonal antibodies and complement.
    Freedman AS; Takvorian T; Nadler LM; Anderson KC; Sallan SE; Ritz J
    Cancer Treat Res; 1988; 38():265-83. PubMed ID: 2908599
    [No Abstract]   [Full Text] [Related]  

  • 9. Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia.
    Guyotat D; Shi ZH; Campos L; Rabat M; Bonnier S; Poncelet P; Laurent JC; Fiere D
    Bone Marrow Transplant; 1990 Dec; 6(6):385-90. PubMed ID: 1982926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination of malignant clonogenic cells from human bone marrow using multiple myeloid cell-specific monoclonal antibodies and complement.
    Hu ZB; Yu ZF; Qiao CN; Ma WL
    Chin Med J (Engl); 1991 Aug; 104(8):664-8. PubMed ID: 1914634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomagnetic bone marrow purging of common acute lymphoblastic leukemia cells: suitability of BioMag particles.
    Trickett AE; Ford DJ; Lam-Po-Tang PR; Vowels MR
    Bone Marrow Transplant; 1991 Mar; 7(3):199-203. PubMed ID: 2059757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
    Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
    Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts.
    Humblet Y; Feyens AM; Sekhavat M; Agaliotis D; Canon JL; Symann ML
    Cancer Res; 1989 Sep; 49(18):5058-61. PubMed ID: 2548708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis.
    Slaper-Cortenbach IC; Admiraal LG; van Leeuwen EF; Kerr JM; von dem Borne AE; Tetteroo PA
    Exp Hematol; 1990 Jan; 18(1):49-54. PubMed ID: 2298269
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.